Literature DB >> 24591950

The effect of cell type on surgico-pathologic risk factors in endometrial cancer.

Ahmet Taner Turan1, Betül Dündar1, Burcu Gündoğdu1, Abdullah Boztosun2, Nejat Ozgül1, Nurettin Boran1, Gökhan Tulunay1, Ahmet Ozfuttu3, Mehmet Faruk Köse1.   

Abstract

OBJECTIVE: In this study the effect of histologic subtype as a surgicopathologic risk factor in endometrial cancer is evaluated.
MATERIAL AND METHODS: We evaluated 182 patients who underwent systematic lymphadenectomy up to the level of the renal vessels and at least 15 lymph nodes were dissected from the pelvic area and 10 lymph nodes from the para-aortic area. investigation of whether endometrioid and aggressive cell types (serous papillary cell and clear cell) affect the distribution of surgicopathologic risk factors among endometrial cancer cases was carried out.
RESULTS: Patients in the aggressive cell type group were older and the tumor size was significantly smaller. There was no difference between the two groups for the total number of dissected lymph nodes except for the external iliac area. Although the difference is not statistically significant, the total number of lymph nodes dissected in the aggressive group was less (54.3 vs 62.9, p=0.067) than that of the endometrioid cell type group. While the incidence of pelvic lymph node metastasis in the aggressive group was 59.1% the incidence was 15.6% in the endometrioid cell type group (p>0.001). The possibility of lymph node metastasis for aggressive cell type endometrial carcinoma in the para-aortic area was twice the endometrioid cell type group. It was found that the presence and type (stromal/glandular) of cervical invasion, depth of myometrial invasion and presence of lymphovascular space invasion were not affected by cell type.
CONCLUSION: Aggressive cell types significantly increase the adnexial and lymph node metastasis in endometrial cancer.

Entities:  

Keywords:  Endometrial carcinoma; cell type

Year:  2011        PMID: 24591950      PMCID: PMC3939298          DOI: 10.5152/jtgga.2011.03

Source DB:  PubMed          Journal:  J Turk Ger Gynecol Assoc        ISSN: 1309-0380


  31 in total

1.  Uterine serous carcinoma. A morphologically diverse neoplasm with unifying clinicopathologic features.

Authors:  M E Sherman; P Bitterman; N B Rosenshein; G Delgado; R J Kurman
Journal:  Am J Surg Pathol       Date:  1992-06       Impact factor: 6.394

Review 2.  Chemotherapy as adjuvant and salvage treatment in women with endometrial carcinoma.

Authors:  T W Burke; D M Gershenson
Journal:  Clin Obstet Gynecol       Date:  1996-09       Impact factor: 2.190

3.  Clear cell carcinoma of the endometrium: an analysis of 21 cases.

Authors:  R J Kurman; R E Scully
Journal:  Cancer       Date:  1976-02       Impact factor: 6.860

4.  Cancer statistics, 1999.

Authors:  S H Landis; T Murray; S Bolden; P A Wingo
Journal:  CA Cancer J Clin       Date:  1999 Jan-Feb       Impact factor: 508.702

5.  Serous papillary carcinoma of the endometrium: a histopathological study of 22 cases.

Authors:  V M Abeler; K E Kjørstad
Journal:  Gynecol Oncol       Date:  1990-12       Impact factor: 5.482

6.  Nodal distribution and its significance in FIGO stage IIIc endometrial cancer.

Authors:  D S McMeekin; D Lashbrook; M Gold; D R Scribner; S Kamelle; T D Tillmanns; R Mannel
Journal:  Gynecol Oncol       Date:  2001-08       Impact factor: 5.482

7.  Uterine papillary serous carcinoma: patterns of metastatic spread.

Authors:  B A Goff; D Kato; R A Schmidt; M Ek; J A Ferry; H G Muntz; J M Cain; H K Tamimi; D C Figge; B E Greer
Journal:  Gynecol Oncol       Date:  1994-09       Impact factor: 5.482

8.  Systematic pelvic and aortic lymphadenectomy in intermediate and high-risk endometrial cancer: lymph-node mapping and identification of predictive factors for lymph-node status.

Authors:  Christina Fotopoulou; Konstantinos Savvatis; Robert Kraetschell; Joerg C Schefold; Werner Lichtenegger; Jalid Sehouli
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2010-01-22       Impact factor: 2.435

9.  Endometrial carcinoma: the prognostic impact of papillary serous carcinoma (UPSC) in relation to nuclear grade, DNA ploidy and p53 expression.

Authors:  B Nordström; P Strang; A Lindgren; R Bergström; B Tribukait
Journal:  Anticancer Res       Date:  1996 Mar-Apr       Impact factor: 2.480

10.  Prospective assessment of lymphatic dissemination in endometrial cancer: a paradigm shift in surgical staging.

Authors:  Andrea Mariani; Sean C Dowdy; William A Cliby; Bobbie S Gostout; Monica B Jones; Timothy O Wilson; Karl C Podratz
Journal:  Gynecol Oncol       Date:  2008-03-04       Impact factor: 5.482

View more
  1 in total

1.  Association of endothelial nitric oxide synthase gene polymorphisms with endometrial carcinoma: a preliminary study.

Authors:  Ebru Oztürk; Ebru Dikensoy; Ozcan Balat; Mete Gürol Uğur; Sibel Oğuzkan Balcı; Abdullah Aydın; Ulkü Kazancı; Sacide Pehlivan
Journal:  J Turk Ger Gynecol Assoc       Date:  2011-12-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.